The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 996.80
Bid: 999.80
Ask: 1,000.50
Change: 11.20 (1.14%)
Spread: 0.70 (0.07%)
Open: 985.00
High: 1,006.00
Low: 984.20
Prev. Close: 985.60
SN. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

10 Mar 2016 17:31

RNS Number : 7558R
Smith & Nephew Plc
10 March 2016
 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

 

SMITH & NEPHEW PLC

 

10 March 2016

 

Smith & Nephew plc announces that it has today been informed of the following transactions by Directors and persons discharging managerial responsibilities ("PDMRs") in relation to conditional awards over shares:

 

1. FINAL VESTING ON 7 MARCH 2016 OF 2013 EQUITY INCENTIVE AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2010:

 

Name of Director / PDMR

Number of Ordinary Shares acquired (iii)

Number of Ordinary Shares sold

Total Ordinary Shares / ADS' held following notification

Olivier Bohuon

28,767

(ii) 13,554

416,213 Ordinary Shares

John Campo

9,078

(ii) 4,287

84,922 Ordinary Shares (including 10,545 ADS')

Michael Frazzette

10,186

(ii) 3,859

102,303 Ordinary Shares (including 37,120 ADS')

Elga Lohler

4,177

0

32,679 Ordinary Shares (including 3,015 ADS')

Cyrille Petit

5,419

(ii) 2,556

48,991 Ordinary Shares

 

(i) The awards were granted under the Global Share Plan 2010 on 7 March 2013. One third of the shares vested on 7 March 2014, a further third vested on 7 March 2015 and the final third vested on 7 March 2016.

(ii) Ordinary Shares were sold to cover taxation obligations arising on the vesting of the awards.

(iii) This number includes the dividend equivalent shares which participants receive on vested shares.

 

 

2. PARTIAL VESTING ON 7 MARCH 2016 OF 2014 EQUITY INCENTIVE AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2010:

 

Name of Director / PDMR

Number of Ordinary Shares acquired (iii)

Number of Ordinary Shares sold

Total Ordinary Shares / ADS' held following notification

Olivier Bohuon

21,222

(ii) 10,000

416,213 Ordinary Shares

Julie Brown

9,118

(ii) 4,301

90,040 Ordinary Shares

Rodrigo Bianchi

3,233

0

58,504 Ordinary Shares

John Campo

6,595

(ii) 3,114

84,922 Ordinary Shares (including 10,545 ADS')

Bradley Cannon

3,926

(iv) 2,707

14,390 Ordinary Shares

Michael Frazzette

7,558

(ii) 2,864

102,303 Ordinary Shares (including 37,120 ADS')

Elga Lohler

2,950

0

32,679 Ordinary Shares (including 3,015 ADS')

Cyrille Petit

6,198

(ii) 2,924

48,991 Ordinary Shares

 

(i) The awards were granted under the Global Share Plan 2010 on 7 March 2014. One third of the shares vested on 7 March 2015 and a further third vested on 7 March 2016. The final third will vest on 7 March 2017.

(ii) Ordinary Shares were sold to cover taxation obligations arising on the vesting of the awards.

(iii) This number includes the dividend equivalent shares which participants receive on vested shares.

(iv) Some of the Ordinary Shares were sold to cover taxation obligations arising on the vesting of the awards.

 

3. PARTIAL VESTING ON 9 MARCH 2016 OF 2015 EQUITY INCENTIVE AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2010:

 

Name of Director / PDMR

Number of Ordinary Shares acquired (iii)

Number of Ordinary Shares sold

Total Ordinary Shares / ADS' held following notification

Olivier Bohuon

13,073

(ii) 6,166

416,213 Ordinary Shares

Julie Brown

8,380

(ii) 3,953

90,040 Ordinary Shares

Rodrigo Bianchi

8,041

0

58,504 Ordinary Shares

John Campo

5,518

(ii) 2,606

84,922 Ordinary Shares (including 10,545 ADS')

Bradley Cannon

3,613

(iv)2,491

14,390 Ordinary Shares

Michael Frazzette

6,955

(ii) 2,635

102,303 Ordinary Shares (including 37,120 ADS')

Elga Lohler

3,046

0

32,679 Ordinary Shares (including 3,015 ADS')

Cyrille Petit

5,543

(ii) 2,615

48,991 Ordinary Shares

Glenn Warner

3,315

(ii) 1,187

6,616 Ordinary Shares (including 915 ADS')

 

(i) The awards were granted under the Global Share Plan 2010 on 9 March 2015. One third of the shares vested on 9 March 2016, a further third will vest on 9 March 2017 and the final third will vest on 9 March 2018.

(ii) Ordinary Shares were sold to cover taxation obligations arising on the vesting of the awards.

(iii) This number includes the dividend equivalent shares which participants receive on vested shares.

(iv) Some of the Ordinary Shares were sold to cover taxation obligations arising on the vesting of the awards.

 

 

 

4. VESTING ON 7 MARCH 2016 OF 2013 SMITH & NEPHEW GLOBAL SHARE PLAN (PERFORMANCE SHARE AWARDS):

 

Name of Director / PDMR

Number of Ordinary Shares acquired (iii)

Number of Ordinary Shares sold

Total Ordinary Shares / ADS' held following notification

Olivier Bohuon

84,505

(ii) 39,817

416,213 Ordinary Shares

Julie Brown

46,603

(ii) 21,963

90,040 Ordinary Shares

John Campo

18,245

(ii) 8,607

84,922 Ordinary Shares (including 10,545 ADS')

Bradley Cannon

10,426

(iv)7,188

14,390 Ordinary Shares

Michael Frazzette

20,471

(ii) 7,749

102,303 Ordinary Shares (including 37,120 ADS')

Elga Lohler

6,716

0

32,679 Ordinary Shares (including 3,015 ADS')

Cyrille Petit

16,187

(ii) 7,630

48,991 Ordinary Shares

 

(i) The awards were granted under the Global Share Plan 2010 on 7 March 2013 and as announced on 12 February 2016, vested at 33% of maximum and settled on 7 March 2016.

(ii) Ordinary Shares were sold to cover taxation obligations arising on the vesting of the awards.

(iii) This number includes the dividend equivalent shares which participants receive on vested shares.

(iv) Some of the Ordinary Shares were sold to cover taxation obligations arising on the vesting of the awards.

 

5. VESTING ON 7 MARCH 2016 OF 2013 SMITH & NEPHEW GLOBAL SHARE PLAN CONDITIONAL SHARE AWARD:

 

Name of PDMR

Number of Ordinary Shares acquired

Number of Ordinary Shares sold

Total Ordinary Shares / ADS' held following notification

Bradley Cannon

20,000

(ii) 13,789

14,390 Ordinary Shares

 

(i) The award was granted under the Global Share Plan 2010 on 7 March 2013.

(ii) Some of the Ordinary Shares were sold to cover taxation obligations arising on the vesting of the awards.

 

 

Additional Notes:

 

1. The Ordinary Shares were released and sold in London, UK.

 

2. The market value of Ordinary Shares acquired and sold on 7 March 2016 was 1,136.62p per Ordinary Share. The closing mid-market price on 7 March 2016 was 1138p per Ordinary Share.

 

3. The market value of Ordinary Shares acquired and sold on 9 March 2016 was 1,134p per Ordinary Share. The closing mid-market price on 9 March 2016 was 1130p per Ordinary Share.

 

4. The percentages of issued share capital acquired, disposed and held following notification are all under 0.01% of the total issued share capital of the Company.

 

5. One ADS is the equivalent of two Ordinary Shares of US$0.20 each.

 

 

This announcement is made in accordance with the requirements of DTR 3.1.4 R (1)(a)

 

 

Vickie Reuben

Deputy Company Secretary

Smith & Nephew plc

 

Tel: 020 7401 7646

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFFDVTIILIR
Date   Source Headline
24th Mar 20204:39 pmRNSPrice Monitoring Extension
20th Mar 20204:47 pmRNSSecond Price Monitoring Extn
20th Mar 20204:38 pmRNSPrice Monitoring Extension
18th Mar 20204:38 pmRNSPrice Monitoring Extension
10th Mar 20205:32 pmRNSDirector/PDMR Shareholding
9th Mar 20205:06 pmRNSDirector/PDMR Shareholding
5th Mar 202012:55 pmRNSHolding(s) in Company
5th Mar 20207:01 amRNSDirectorate Change
5th Mar 20207:00 amRNSDirectorate Change
2nd Mar 20205:00 pmRNSAnnual Financial Report
2nd Mar 20203:46 pmRNSTransaction in Own Shares
2nd Mar 20201:46 pmRNSTotal Voting Rights
25th Feb 20206:20 pmRNSTransaction in Own Shares
24th Feb 20205:52 pmRNSTransaction in Own Shares
24th Feb 202011:12 amRNSDirector/PDMR Shareholding
21st Feb 20204:11 pmRNSDirector/PDMR Shareholding
21st Feb 202010:48 amRNSTransaction in Own Shares
20th Feb 20207:00 amRNSFourth Quarter and Full Year 2019 Results
20th Feb 20207:00 amRNSFourth Quarter and Full Year 2019 Results
7th Feb 20203:10 pmRNSDirector/PDMR Shareholding
6th Feb 20208:24 amRNSDirector Declaration
3rd Feb 20202:25 pmRNSBlock listing Interim Review
3rd Feb 202011:24 amRNSTotal Voting Rights
24th Jan 20207:00 amRNSSmith+Nephew acquires Tusker Medical, Inc.
21st Jan 20203:00 pmRNSNotice of Results
16th Jan 20203:56 pmRNSDirector/PDMR Shareholding
2nd Jan 202010:34 amRNSTotal Voting Rights
2nd Dec 20194:34 pmRNSAdditional Listing
2nd Dec 201912:13 pmRNSTotal Voting Rights
20th Nov 20199:17 amRNSDirector/PDMR Shareholding
14th Nov 20199:17 amRNSDirector/PDMR Shareholding
12th Nov 20194:21 pmRNSTransaction in Own Shares
8th Nov 201912:54 pmRNSTransaction in Own Shares
8th Nov 20199:07 amRNSDirector/PDMR Shareholding
7th Nov 20195:33 pmRNSTransaction in Own Shares
6th Nov 20195:56 pmRNSTransaction in Own Shares
6th Nov 20193:05 pmRNSDirector/PDMR Shareholding
5th Nov 20196:13 pmRNSTransaction in Own Shares
4th Nov 20191:07 pmRNSDirector Declaration
4th Nov 201911:50 amRNSTransaction in Own Shares
1st Nov 20191:24 pmRNSDirector/PDMR Shareholding
1st Nov 201910:53 amRNSTotal Voting Rights
31st Oct 20194:43 pmRNSDirector/PDMR Shareholding
31st Oct 201911:21 amRNSDirector/PDMR Shareholding
31st Oct 20197:00 amRNSTrading Statement
21st Oct 20197:00 amRNSDirectorate Change
18th Oct 20199:17 amRNSDividend Declaration
15th Oct 20191:14 pmRNSNotification of Major Holdings in Company
14th Oct 20198:56 amRNSNotification of Major Holdings in Company
3rd Oct 201911:15 amRNSNotification of Major Holdings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.